Sign in
4/A

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-023327

Chief Executive Officer sold 200 shares at $38.40 ($7,680)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ciechanover Isaac E. Chief Executive Officer 2018-03-27 Sale −200 $38.40 $7,680 206,478 I
Open-market sales · 200 sh · avg $38.40 · $7,680
Loading xslF345X03/doc4a.xml…